Medical Hypotheses
Volume 59, Issue 3 , Pages 302-311 , September 2002

Does the pineal gland have a role in the psychological mechanisms involved in the progression of cancer?

  • B.D Callaghan

      Affiliations

    • Corresponding Author InformationCorrespondence to: B.D. Callaghan MBBS (Melb.) MD (Adel.), FRACS, FRCS, FRCSE. Department of Anatomical Sciences, University of Adelaide, Adelaide, South Australia, 5005, Australia. Phone: 08-83035998. My office telephone No. 08-83035480; Fax: +61-8-8303-4398

Received 9 November 2001 ,Accepted 13 February 2002.

References 

  1. Bahnson CB. Stress and cancer: the state of the art. Psychosomatics. 1980;21(part 1):975–981
  2. Kowal SJ. Emotions as a cause of cancer:18th and 19th century contributions. Psychoanal. Rev. 1955;42:217–227
  3. Evans E. A Psychological Study of Cancer. New York, Dodd: Mead, 1926
  4. Eysenck HJ. The respective importance of personality, cigarette smoking and interaction effects for the genesis of cancer and heart disease. Person. Individ. Diff. 1988;9:453–464
  5. Bahnson CB, Bahnson MB. Denial and repression of primitive impulses and of disturbing emotions in patients with malignant neoplasms. In:  Kissen DM,  LeShan L editor. Psychosomatic Aspects of Neoplastic Disease. Philadelphia: Lippincott; 1964;p. 42–62
  6. Kune GA, Kune S, Watson LF, Bahnson CB. Personality as a risk factor in large bowel cancer. Data from the Melbourne Colorectal Cancer study. Psychol. Med. 1991;21:29–41
  7. Lehrer S. Life change and gastric cancer. Psychosom. Med. 1980;42:499–502
  8. Horne RL, Picard RS. Psychosocial risk factors in lung cancer. Psychosom. Med. 1979;41:503–514
  9. Bremond A, Kune GA, Bahnson CB. Psychosomatic factors in breast cancer patients. Results of a case control study. J. Psychosom. Obstet. Gynaecol. 1986;5:127–136
  10. Kune S, Kune GA, Watson LF, Rahe RH. Recent life changes and large bowel cancer. Data from the Melbourne Colorectal Cancer study. J. Clin. Epidemiol. 1991;44:57–68
  11. Donovan BT. Stress. In:  Donovan BT editors. Humours, Hormones and the Mind. Stockton Press: Year Book Medical Publishers; 1988;p. 172–184
  12. Kune GA, Kune S, Watson LF. Perceived religiousness is protective for colorectal cancer: Data from the Melbourne Colorectal cancer study. J. R. Soc. Med. 1993;86:645–647
  13. Kune GA. The Psyche and the development of malignant disease. In:  Kune GA,  Bannerman S editor. The Psyche and Cancer. Melbourne: University of Melbourne Press; 1992;p. 11–14
  14. Brown GM, Seggie J, Ettigi P. Stress, Hormone Responses, and Cancer. In:  Tache J,  Selye H,  Day SB editor. Cancer Stress and Death. New York, London: Plenum Book Company; 1979;p. 29–41
  15. Guex P. Psychosomatics in cancer. In:  Guex P editors. An Introduction to Psycho-oncology. London, New York: Routledge; 1989;p. 1–10
  16. Sklar LS, Anisman H. Social stress influences tumour growth. Psychosom. Med. 1980;42(3):347–365
  17. Sakakibara T. Effect of brightness or darkness on carcinogenesis. J. Nagoya City Univ. Med. Assoc. 1968;19:525–557
  18. Bennett TL. In: Brain and Behaviour. Momterey, California: Brooks/Love Publishing Company; 1977;p. 146
  19. Kim C, Chang UK. Effect of partial hippocampal resection on stress mechanism in rats. Am. J. Physiol. 1961;201(2):337–340
  20. Moore-Ede MC, Molise ML. Ciba foundation symposium. In: Melatonin and the Pineal. Circadian Rhythms and Photoperiodism. London: Churchill Livingstone; 1985;p. 117
  21. Beck-Friis J, Kjellman BF, Ljunggren J-G, Wetterberg L. The pineal gland and melatonin in affective disorders. In:  Brown GM,  Wainwright SD editor. The Pineal Gland: Endocrine Aspects. Oxford, New York, Toronto: Pergamon Press; 1985;p. 313–325
  22. McIntyre IH, Judd FK, Norman TR, Burrows GD. Plasma melatonin levels in depression. Aust. N. Z. J. Psychiatry. 1986;20:381–383
  23. Seggie J, Campbell L, Brown GM, Grota LJ. Melatonin and N-Acetylserotonin stress responses:Effect of type of stimulation and housing conditions. J. Pineal Res. 1985;2:39–49
  24. Kachi T. Pineal actions on the autonomic system. Pineal Res. Rev. 1987;5:217–263
  25. Webb SM, Puig-Domingo M. Role of melatonin in health and disease. Clin. Endocrinol. 1995;42:221–234
  26. Chrousos GP. Stress as a medical and scientific idea and its implications. Adv. Pharmacol. 1998;42:552–556
  27. Seggie J, Brown GM. Coping with stress: parallelism between the effects of septal lesions on growth hormone and corticosterone levels. Biol. Psychiatry. 1976;11:583–597
  28. Syvalahti E, Lammintausta R, Pekkarinen A. Effect of psychic stress of examination on serum growth hormone, serum insulin and plasma renin activity. Acta. Pharmacol. Toxicol. 1976;38:344–352
  29. Stein M, Keller S, Schleifer S. Role of hypothalamus in mediating stress effects on the immune system. In:  Stoll BA editors. Mind and Cancer Prognosis. Chichester, New York: John Wiley; 1979;p. 86–101
  30. Bindoni M, Belluardo N, Licciardello S, Marchese AE, Cicirata F. Growth of Yoshida ascites tumour in the rat after radiofrequency destruction of the tuberoinfundibular region of the hypothallamus. Neuroendocrinology. 1980;30:88–93
  31. Bindoni M, Belluardo N, Marchese AE, Mudo G, Laguidara A. Labelling index of L 1210 and Ehrlich ascites tumour cells after radiofrequency destruction of the tuberoinfundibular region of the hypothalamus in the mouse. Neuroendocrinol. Lett. 1981;3:347–354
  32. Bindoni M, Belluardo N, Marchese AE, et al.  Increased tumour cell multiplication after radiofrequency lesions in the median hypothalamus in the mouse and rat. Neuroendocrinology. 1986;42:407–415
  33. Tutton PJ, Barkla DH. A comparison of cell proliferation in normal and neoplastic intestinal epithelia following either biogenic amine depletion or monoamine oxidase inhibition. Virchows Arch. B. 1976;21:161–168
  34. Williams LM, Hannah LT, Hastings MH, Maywood ES. Melatonin receptors in the rat brain and pituitary. J. Pineal Res. 1995;19:173–177
  35. Anton-Tay F, Wurtman RJ. Regional uptake of 3 H-melatonin from blood or cerebrospinal fluid by rat brain. Nature. 1969;221:474–475
  36. Brown G, Grota L, Niles L. Melatonin: origin control of circadian rhythm and site of action. In:  Birau N,  Schloot W editor. Current Status and Perspectives. Advances in the Biosciences. Vol. 29:Oxford, New York: Pergamon Press; 1981;p. 193–196
  37. Miguez J, Martin F, Aldegunde M. Differential effects of pinealectomy on amygdala and hippocampus serotonin metabolism. J. Pineal Res. 1991;10:100–103
  38. Korf H-W, Wagner V. Evidence for a nervous connection between the brain and the pineal organ in the guinea pig. Cell Tissue Res. 1980;209:505–510
  39. Ariens-Kappers J, Smith RJ, DeVries RAC. The mammalian pineal gland and its control of hypothalamic activity. Prog. Brain Res. 1974;41:149–174
  40. Stoll BA. Selective mechanisms in hormonal therapy. In:  Stoll BA editors. Secondary Spread in Breast Cancer. Vol. 3:London: Heinemann Medical; 1977;p. 169–171
  41. Bariga C, Martin MI, Tabla R, Ortega E, Rodriguez AB. Circadian rhythm of melatonin, corticosterone and phagocytosis: effect of stress. J. Pineal Res. 2001;30:180–187
  42. Callaghan BD, Firth BT. An effect of pinealectomy on rat small intestinal crypt cell kinetics. IRCS Med. Sci. 1978;6:540
  43. Callaghan BD. The effect of bilateral amygdaloid nucleus lesions on rat small bowel crypt cell kinetics. Virchows Arch. B. 1989;57:231–236
  44. Callaghan BD. The effect of bilateral hippocampal lesions and autonomic denervation of the small bowel on rat crypt cell kinetics. Med. Sci. Res. 1989;17:825–826
  45. Callaghan BD. Effect of septal and fornix lesions on rat small bowel crypt cell kinetics. Digestion. 1990;45:34–39
  46. Preston-Martin S, Pike ML, Ross RK, Jones PA, Henderson BE. Increased cell division as a cause of human cancer. Cancer Res. 1990;50:7415–7421
  47. Poletti CE. Is the limbic system a system? Studies of hippocampal efferents: their functional and clinical applications. In:  Doane BK,  Livingston KE editor. The Limbic System: Functional Organization and Clinical Disorders. New York: Raven Press; 1986;p. 79–84
  48. Hogan MV, El-Sherif Y, Wieraszko A. The modulation of neuronal activity by melatonin: in vitro studies on mouse hippocampal slices. J. Pineal Res. 2001;30:87–96
  49. Tamarkin L, Cohen M, Rosello D, Reichart C, Lippman M, Chabner B. Melatonin inhibition and pinealectomy enhancement of 7,12- 7,12- 7,12-dimethylbenzantracene-induced mammary tumours in the rat. Cancer Res. 1981;41:4432–4436
  50. Bartsch H, Bartsch C. Effect of melatonin on experimental tumours under different photoperiods and times of administration. J. Neural Transm. 1981;52:269–279
  51. Narita T, Kudo H. Effect of B16 melatonin on melanoma growth in athymic mice. Cancer Res. 1985;45:4175–4177
  52. Blask DE, Wilson ST, Lemus-Wilson AM. The oncostatic and oncomodulatory role of the pineal gland and melatonin. Adv. Pineal Res. 1994;7:235–241
  53. Bartsch C, Bartsch H, Fluchter SH, Mecke D, Lippert TH. Diminished pineal function coincides with disturbed circadian endocrine rhythmicity in untreated primary cancer patients. Consequence of premature aging or of tumour growth?. Ann. N.Y. Acad. Sci. 1994;719:502–525
  54. Bartsch C, Kvetnoy I, Kvetnaia T, et al.  Nocturnal urinary 6-sulphatoxymelatonin and proliferating cell nuclear antigen-immunopositive tumour cells show strong positive correlations in patients with gastrointestinal and lung cancer. J. Pineal Res. 1997;23:90–96
  55. Cos S, Blask DE. Melatonin modulates growth factor activity in MCF-7 human breast cancer cells. J. Pineal Res. 1994;17:25–32
  56. Karasek M, Liberski P, Kunert-Radek J, Bartkowiak J. Influence of melatonin on the proliferation of hepatoma cells in the Syrian hamster: in vivo and in vitro study. J. Pineal Res. 1992;13:107–110
  57. Conti A, Maestroni GJ. The clinical neuroimmunotherapeutic role of melatonin in oncology. J. Pineal Res. 1995;19:103–110
  58. Huerto Delgadillo L, Anton-Tay F, Benitez G. Effects of melatonin on microtubule assembly depend on hormone concentration: role of melatonin as a calmodulin antagonist. J. Pineal Res. 1994;17:55–62
  59. Khoory R, Stemme D. Plasma melatonin levels in patients suffering from colorectal carcinoma. J. Pineal Res. 1988;5:251–258
  60. Karasek M, Dec W, Kowalski AJ, Bartsch H, Bartsch C. Serum melatonin circadian profile in women with adenocarcinoma of uterine corpus. Int. J. Thymol. 1996;4(suppl. 1):80–83
  61. Karasek M, Winczyk K, Kunert-Radek J, Wiesenberg I, Pawlikowski M. Antiproliferative effects of melatonin and CGP 52608 on the murine Colon 38 adenocarcinoma in vitro and in vivo. Neuroendocrinol. Lett. 1998;19:71–78
  62. Anisimov VN. Melatonin and colon carcinogenesis. In:  Bartsch C,  Bartsch H,  Blask DE,  Cardinali DP,  Hrushesky WJM,  Mecke D editor. The Pineal Gland and Cancer. Berlin, Heidelberg, New York: Springer-Verlag; 2001;p. 241–258
  63. Itoh M, Guth PH. Role of oxygen-derived free radicals in hemorrhagic shock-induced gastric lesions in the rat. Gastroenterology. 1985;88:1162–1167
  64. Jackson JH. Potential molecular mechanisms of oxidant-induced carcinogenesis. Environ. Health Perspect. 1994;102(suppl. 10):155–157
  65. Reiter RJ, Tan DX, Cabrera J, et al.  The oxidant/antioxidant network: role of melatonin. Biol. Signals Recept. 1999;8:56–63
  66. Panzer A, Viljoen M. The validity of melatonin as an oncostatic agent. J. Pineal Res. 1997;22:184–202
  67. Booth FM. The human pineal gland:a review of the `third eye' and the effect of light. Aust. N. Z. J. Ophthalmol. 1987;15:329–336
  68. Williams LM, Hannah LT, Hastings MH, Maywood ES. Melatonin receptors in the rat brain and pituitary. J. Pineal Res. 1995;19:173–177
  69. Reiter RJ. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr. Rev. 1991;12:151–180
  70. Molis TM, Spriggs LL, Jupiter Y, Hill SM. Melatonin modulation of estrogen-regulated proteins, growth factors, and proto-oncogenes in human breast cancer. J. Pineal Res. 1995;18:93–103
  71. Lissoni P. Melatonin and cancer treatment. In:  Watson RR editors. Melatonin in the Promotion of Health. Boca Raton, London, New York: CRC Press; 1999;p. 175–189
  72. Lichtenstein P, Holm NV, Verkasalo PK, et al.  Environmental and heritable factors in the causation of cancer. N. Eng. J. Med. 2000;343:78–85
  73. Lissoni P, Tisi E, Brivio F, et al.  Modulation of interleukin-2-induced macrophage activation in cancer patients by the pineal hormone melatonin. J. Biol. Regul. Homeost. Agents. 1991;5:154–156
  74. Maestroni GJM. The immunoendocrine role of melatonin. J. Pineal Res. 1993;14:1–10
  75. Bahnson CB. Stress and cancer: the state of the art. Part 2. Psychosomatics. 1981;22:207–220
  76. Cross RJ, Markesbury WR, Brooks WH, Roszman TL. Hypothalamic-immune interactions; 1-the acute effect of anterior hypothalamic lesions on the immune response. Brain Res. 1980;196:79–87
  77. Brooks WH, Cross RJ, Roszman TL, Markesbury WR. Neuroimmunomodulation: neuroanatomical basis for impairment and facilitation. Ann. Neurol. 1982;12:56–61
  78. Irwin J, Anisman H. Stress and pathology: immunological and central nervous system interactions. In:  Cooper CL editors. Psychosocial Stress in Cancer. Chichester: John Wiley; 1984;p. 93–147
  79. Locke SE, Kraus L. Modulation of natural killer cell activity by life stress and coping ability. In:  Levy SM editors. Biological Mediators of Behaviour and Disease: Neoplasia. New York: Elsevier Biomedical; 1982;p. 3–28
  80. Schleifer SJ, Keller SE, Camerino M, Thornton JC, Stein M. Suppression of lymphocyte stimulation following bereavement. JAMA. 1983;250:374–377
  81. Keller SE, Weiss JM, Schleifer SJ, Miller NE, Stein M. Suppresssion of immunity by stress: effects of a graded series of stressors on lymphocyte stimulation in the rat. Science. 1981;213:1397–1400
  82. Acuna-Castroviejo D, Escames G, Macias M, et al.  Cell protective role of melatonin in the brain. J. Pineal Res. 1995;19:57–63
  83. Stoll BA. Will to live and survival time in cancer. In:  Stoll BA editors. Prolonged Arrest of Cancer. Chichester: John Wiley; 1982;p. 117–134
  84. Keynes WM. Medical response to mental stress. J. R. Soc. Med. 1994;87:536–539
  85. Spiegel D, Bloom JR, Kraemer HC, Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet. 1989;ii:888–891
  86. Greer S, Morris T, Pettingale KW, Haybittle JL. Psychological response to breast cancer and 15 year outcome. Lancet. 1990;335:49–50
  87. Reiter RJ. Melatonin: that ubiquitously acting pineal hormone. News Physiol. Sci. 1991;6:223–227
  88. Callaghan BD. The role of the pineal gland in neural control of cell proliferation in healthy and malignant tissue. In:  Bartsch C,  Bartsch H,  Hrushesky WJM,  Blask DE,  Cardinali DP,  Mecke D editor. The Pineal Gland and Cancer. Berlin, Heidelberg, New York: Springer; 2001;p. 417–441
  89. Scheiman JM, Boland CR. Neoplasia of the gastrointestinal tract. In:  Henderson JM editors. Gastrointestinal pathophysiology. Philadelphia: Lippincott-Raven; 1996;p. 235–261
  90. Nugent KP. Colorectal cancer: surgical prophylaxis and chemoprevention. Ann. R. Coll. Surg. Engl. 1995;77:372–376
  91. Pierceall WE, Mukhopadhyay T, Goldberg LH, Ananthaswamy HN. Mutations in the p 53 tumour suppressor gene in human cutaneous squamous cell carcinomas. Mol. Carcinog. 1991;4:445–449
  92. Gao S, Drouin R, Holmquist GP. DNA repair rates mapped along the human PGK 1 gene at nucleotide resolution. Science. 1994;263:1438–1440
  93. Koratkar R, Vasudha A, Ramesh G, Padma M, Das UN. Effect of melatonin cis-platinum induced genetic damage to the bone marrow cells of mice. Med. Sci. Res. 1992;20:179–180
  94. Meares A. Regression of cancer after intensive meditation (preliminary report). Med. J. Aust. 1976;2:184
  95. Starr KW. Growth and new growth: environmental carcinogens in the process of human ontogeny. Prog. Clin. Cancer. 1970;4:1–29
  96. Lissoni P, Barni S, Tancini G, et al.  A randomised study with subcutaneous low dose interleukin-2 alone vs interleukin-2 plus the pineal neurohormone melatonin in advanced solid neoplasm other than renal cancer and melanoma. Br. J. Cancer. 1994;69:196–199

PII: S0306-9877(02)00173-1

Medical Hypotheses
Volume 59, Issue 3 , Pages 302-311 , September 2002

Article Tools

* Image Usage & Resolution